February 16, 2010, 11 am Eastern Time
(10 am Central, 9 am Mountain, 8 am Pacific)
Management of Hyperglycemia for Patients with Heart Disease:
“How Low Should We Go?”
Presented By:Mary Korytkowski, MD
Professor of Medicine in the Division of Endocrinology at the University of Pittsburgh
Attendees earn 1.0 AACVPR Continuing Education Credit
Treatment of hyperglycemia is central to the care of patients with diabetes mellitus. For decades the goal has been to try to normalize blood glucose. This is based on data that the risk of diabetic complications is decreased with improved glucose control. In fact, in the past, glucose levels were rarely normalized. There have been several recent important trials that suggest there may be true harm to patients with cardiovascular disease who are treated very aggressively to lower levels of glucose control than were previously recommended. Thus, recent evidence suggests that for many patients with cardiovascular disease, particularly when they are hospitalized, target blood sugars should be somewhat higher than normal, and higher than prior guidelines. Dr. Kortykowski will review this evidence and suggest practical methods of achieving these latest recommendations.
Upon completion of this Webinar, the participants will be:
- Identify those patients, with cardiovascular events, who are at risk for developing, or may have , untreated diabetes.
- Utilize the current American Diabetic Association (ADA) guidelines and evidence from recent clinical trials, to discuss appropriate glycemic goals for patients with pre- existing cardiovascular disease and diabetes.
- Explore the use of algorithms in the initial and progressive glycemic management of diabetes.
- Describe modifications in diabetic therapy that can minimize risk for hypoglycemia during exercise and cardiac rehabilitation.
To fully participate in this WEBINAR, you will need a phone and a computer with internet access.